This company listing is no longer active
Destiny Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Destiny Pharma has a total shareholder equity of £9.2M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £10.0M and £768.3K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£6.38m |
| Equity | UK£9.19m |
| Total liabilities | UK£768.32k |
| Total assets | UK£9.96m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: D89's short term assets (£7.6M) exceed its short term liabilities (£768.3K).
Long Term Liabilities: D89 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: D89 is debt free.
Reducing Debt: D89 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: D89 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: D89 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.6% each year